Eli Lilly

LLY | NYSE | 111 Followers
$760.22 -0.59% -$4.49
Follow
Overview Metrics Financials
Loading...

Fair Price

$665.15
Overvalued by 03.3%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Eli Lilly and Company (LLY) is an American pharmaceutical company with a long history and significant influence in the global pharmaceutical market. The company specializes in research, development, and manufacturing of medicinal products in various therapeutic areas, including diabetology, oncology, neurology, and others. Eli Lilly offers a wide range of pharmaceutical products and treatment approaches that help improve the health and quality of life of patients worldwide. The company invests in innovation and research to bring new drugs and treatment methods that could potentially change the way diseases are treated. Eli Lilly and Company is a respected name in the pharmaceutical industry and has a strong foundation for further growth and development. Investing in Eli Lilly and Company (LLY) shares may represent an attractive choice for investors seeking a reliable and innovative company in the healthcare sector.

Feed

>3y
Read More

Le Sénat américain a adopté hier, après un débat long et difficile, un projet de loi qui dépensera, ou plutôt utilisera, des centaines de milliards de dollars pour des programmes climatiques et sanitaires tout en augmentant les impôts des grandes entreprises. Dans cet article, nous allons examiner les détails de la "loi sur la réduction de l'inflation" et étudier l'impact sur...
Read more
0
Share
>3y
Read More

Dubravko Lakos (responsable mondial de la recherche macro sur les actions chez JP Morgan) voit une amélioration à l'horizon et un retournement complet des marchés qui fera grimper l'indice S&P 500 à 4 900 points. Les gens s'attendent de facto à une récession, mais Lakos rassure les investisseurs et affirme qu'une récession ne se produira pas au cours des 12 prochains mois. Il...
Read more
0
Share
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade